InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Kunkel Lori Anne. Insider active across 3 companies, notably Oric Pharmaceuticals, Inc.. In total, 11 filings have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €739k. Activity tracked since 3 June 2024. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Kunkel Lori Anne is a director of Enliven Therapeutics, Inc., Oric Pharmaceuticals, Inc. and Nurix Therapeutics, Inc. The record shows 6 filings in total. Across the most recent filings held, the period runs from 2024-06-04 to 2026-06-09, with EUR 297348 of sells and no buys; the modal transaction nature is Disposal.